Catalyst Pharmaceuticals, Inc. (CPRX)

NASDAQ: CPRX · Real-Time Price · USD

20.95

-0.67 (-3.10%)

At close: Jul 15, 2025, 4:00 PM

20.90

-0.05 (-0.24%)

After-hours: Jul 15, 2025, 7:55 PM EDT

Catalyst Pharmaceuticals Market Cap

Catalyst Pharmaceuticals has a market cap or net worth of $2.56 billion as of July 15, 2025. Its market cap has increased by 43.84% in one year.

Market Cap

2.56B

Enterprise Value

1.98B

1-Year Change

43.84%

Ranking

#1773

Market Cap Chart

Since December 15, 2006, Catalyst Pharmaceuticals's market cap has increased from $69.00M to $2.56B, an increase of 3,603.45%. That is a compound annual growth rate of 21.44%.

Market Cap History

Date	Market Cap	% Change
Jul 15, 2025	2.56B	2.66%
Dec 31, 2024	2.49B	38.90%
Dec 29, 2023	1.79B	-7.42%
Dec 30, 2022	1.94B	177.28%
Dec 31, 2021	698.10M	101.65%
Dec 31, 2020	346.20M	-10.40%
Dec 31, 2019	386.40M	95.84%
Dec 31, 2018	197.30M	-40.80%
Dec 29, 2017	333.30M	283.10%
Dec 30, 2016	87.00M	-57.12%
Dec 31, 2015	202.90M	-1.17%
Dec 31, 2014	205.30M	94.41%
Dec 31, 2013	105.60M	599.34%
Dec 31, 2012	15.10M	-52.66%
Dec 30, 2011	31.90M	66.15%
Dec 31, 2010	19.20M	68.42%
Dec 31, 2009	11.40M	-54.94%
Dec 31, 2008	25.30M	-41.44%
Dec 31, 2007	43.20M	-28.60%
Dec 29, 2006	60.50M	-12.32%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	711.91B
Johnson & Johnson	377.51B
AbbVie	339.94B
Novo Nordisk	305.41B
UnitedHealth Group	275.86B
Novartis AG	236.71B
Abbott Laboratories	229.69B
AstraZeneca	218.74B

Market Cap Rankings